Revolution Medicines, Inc.
RVMD
Jodie situation report
Revolution Medicines, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 13 directly disclosed connections are confirming.
- Interest expense tied to the Royalty Purchase Agreement increased by $12.2 million in the three months ended March 31, 2026 versus the same period in 2025.
Invalidation: The isolated read changes if RVMD's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind RVMD
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TNGXTango Therapeutics, Inc.partnerMay 6, 2026 ▾
“Tango Collaboration 80 In November 2024, we entered into a clinical collaboration with Tango Therapeutics, Inc.”
SNYSanofipartnerFeb 25, 2026 ▾
“Sanofi collaboration agreement In June 2018, the Company entered into a collaborative research, development and commercialization agreement (the Sanofi Agreement) with Aventis, Inc.”
Depended on by
TNGXTango Therapeutics, Inc.partnerMay 13, 2026 ▾
“Clinical Trial Collaboration and Supply Agreements In November 2024, the Company and Revolution Medicines, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 17 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
RVMD is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.